18F-FDG PET for Semiquantitative Evaluation of Acute Allograft Rejection and Immunosuppressive Therapy Efficacy in Rat Models of Liver Transplantation

被引:16
作者
Tsuji, Atsushi B. [2 ]
Morita, Miwa [3 ]
Li, Xiao-Kang [1 ]
Sogawa, Chizuru [2 ]
Sudo, Hitomi [2 ]
Sugyo, Aya [2 ]
Fujino, Masayuki [1 ,4 ]
Sugioka, Atsushi [3 ]
Koizumi, Mitsuru [2 ]
Saga, Tsuneo [2 ]
机构
[1] Natl Res Inst Child Hlth & Dev, Lab Transplantat Immunol, Setagaya Ku, Tokyo 1578535, Japan
[2] Natl Inst Radiol Sci, Mol Imaging Ctr, Diagnost Imaging Grp, Chiba 260, Japan
[3] Fujita Hlth Univ, Sch Med, Dept Surg, Aichi, Japan
[4] Natl Inst Hlth, AIDS Res Ctr, Tokyo 141, Japan
关键词
acute rejection; F-18-FDG PET; immunosuppression; liver transplantation; SURVIVAL;
D O I
10.2967/jnumed.108.058925
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Acute allograft rejection remains a major complication after liver transplantation. We report a semiquantitative imaging method of detecting acute allograft rejection with F-18-FDG PET. Methods: Syngeneic and allogeneic transplanted rats, with or without immunosuppressive treatment, were subjected to serial PET. Autoradiography of the liver was conducted in both the syngeneic and the allogeneic rats. Results: A significant increment of F-18-FDG accumulation in liver allografts was observed by PET on day 2. The F-18-FDG signal was concentrated in the area where inflammatory cells around the vessels were detected by autoradiography. Allotransplanted rats treated with an immunosuppressive agent displayed a marked decrease in hepatic F-18-FDG uptake, compared with allotransplanted rats that were not treated. Conclusion: F-18-FDG PET may be a valid method for facilitating the development of protocols to diagnose graft rejection and to monitor the efficacy of immunosuppressive therapy.
引用
收藏
页码:827 / 830
页数:4
相关论文
共 10 条
  • [1] Belle S H, 1997, Liver Transpl Surg, V3, P93, DOI 10.1002/lt.500030201
  • [2] A novel chemical compound, NK026680, targets dendritic cells to prolong recipient survival after rat liver grafting
    Hara, Yoshiaki
    Funeshima-Fuji, Naoko
    Fujino, Masayuki
    Tokunaka, Kazuhiro
    Abe, Fuminori
    Sato, Yoshinobu
    Hatakeyama, Katsuyoshi
    Takahara, Shiro
    Ezaki, Taichi
    Kimura, Hiromistu
    Li, Xiao-Kang
    [J]. TRANSPLANTATION, 2007, 84 (03) : 407 - 414
  • [3] Use of 2-[18F]fluoro-2-deoxyglucose as a potential agent in the prediction of graft rejection by positron emission tomography
    Heelan, BT
    Osman, S
    Blyth, A
    Schnorr, L
    Jones, T
    George, AJT
    [J]. TRANSPLANTATION, 1998, 66 (08) : 1101 - 1103
  • [4] KICG values a reliable real-time estimator of graft function, accurately predicts outcomes in adult living-donor liver transplantation
    Hori, T
    Iida, T
    Yagi, S
    Taniguchi, K
    Yamamoto, C
    Mizuno, S
    Yamagiwa, K
    Isaji, S
    Uemoto, S
    [J]. LIVER TRANSPLANTATION, 2006, 12 (04) : 605 - 613
  • [5] Ishimori T, 2002, J NUCL MED, V43, P658
  • [6] Jones KD, 1998, SEMIN DIAGN PATHOL, V15, P306
  • [7] REVERSAL OF TRANSPLANTATION IMMUNITY BY LIVER GRAFTING
    KAMADA, N
    DAVIS, HFS
    ROSER, B
    [J]. NATURE, 1981, 292 (5826) : 840 - 842
  • [8] Portmann B, 1995, Verh Dtsch Ges Pathol, V79, P277
  • [9] The immunological monitoring of alloreactive responses in liver transplant recipients:: A review
    Reding, R
    Gras, J
    Truong, DQ
    Wieërs, G
    Latinne, D
    [J]. LIVER TRANSPLANTATION, 2006, 12 (03) : 373 - 383
  • [10] Survival after liver transplantation in the United States: A disease-specific analysis of the UNOS database
    Roberts, MS
    Angus, DC
    Bryce, CL
    Valenta, Z
    Weissfeld, L
    [J]. LIVER TRANSPLANTATION, 2004, 10 (07) : 886 - 897